59744-46-6Relevant articles and documents
Access to β-Lactams via Iron-Catalyzed Olefin Oxyamidation Enabled by the I -Accepting Phthalocyanine Ligand
Chang, Sukbok,Kang, Seungju,Kim, Dongwook,Kweon, Jeonguk
, p. 1872 - 1880 (2022/02/01)
Herein, we report the development of an iron-catalyzed olefin oxyamidation by utilizing tethered dioxazolones as the nitrenoid precursor to produce valuable β-lactam scaffolds. Mechanistic studies revealed that a relatively strong I -Accepting ability of
sEH Inhibitor or pharmaceutically acceptable composition thereof as well as preparation method and application thereof
-
Paragraph 0125-0126, (2021/09/21)
The invention provides sEH inhibitor or a pharmaceutically acceptable composition and a preparation method and application thereof, and belongs to the technical field of medicines. sEH Inhibitor or a pharmaceutically acceptable composition thereof according to the present invention is provided, and the sEH inhibitor has the structure shown I. sEH Inhibitor provided by the invention can stabilize an endogenous substance epoxy fatty acid with wide physiological activity, has a strong inhibition effect on human recombinant sEH, and can be used for regulating the generation of a plurality of pro-inflammatory cytokines. The invention relieves the stress of endoplasmic reticulum, prevents or reverses the dysfunction of endothelial dysfunction, stabilizes mitochondria function multiple action mechanisms to obviously relieve neuropathic pain, and can effectively avoid adverse reactions related to the target spot. Furthermore, the sEH inhibitor structure provided by the invention does not contain free carboxyl groups, can avoid adverse reactions such as gastrointestinal irritation caused by oral administration, and is small in adverse reaction, high in bioavailability, excellent in analgesic effect and small in administration amount.
Palladium-Catalyzed Direct C-H Arylation of 3-Butenoic Acid Derivatives
Yang, Shan,Liu, Lingling,Zhou, Zheng,Huang, Zhibin,Zhao, Yingsheng
supporting information, p. 296 - 299 (2021/01/13)
We report herein a direct method to synthesize 4-aryl-3-butenoic acid through a carboxylic-acid-directed oxidative Heck reaction. The various 4-aryl-3-butenoic acids are easily prepared in moderate to good yields. In view of the promising bioactivity of 4-phenyl-3-butenoic acid previously reported, its derivatives reported here may be bioactive.